Navigation Links
Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:9/5/2007

- Company Will Present Seven Posters and sponsor Satellite Symposium at Key

Scientific Gathering at McCormick Place in Chicago, September 17

- 20 -

CHICAGO, Sept. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), will present seven posters on selected cethromycin therapeutic studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) at McCormick Place in Chicago, September 17 - 20. ICAAC, a key scientific event expected to attract more than 12,000 scientists from around the world, is a gathering of leading researchers and clinicians to discuss important themes and present the newest treatment advances in infectious disease. The Advanced Life Sciences booth, #643, will be located in Hall D in the Lakeside Center at McCormick Place.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050428/CGTH039LOGO)

The Advanced Life Sciences poster presentations will discuss in vitro activity of cethromycin against key susceptible and resistant pathogens involved in community acquired pneumonia (CAP) as well as safety data in certain special clinical populations. Along with collaborators such as the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Eurofins Medinet, Micromyx and Battelle, the Company will present data demonstrating the potency of cethromycin against pathogens involved in bioterrorism.

In addition, Advanced Life Sciences is sponsoring a satellite symposium entitled "Drug Resistant CAP, Current and Future Treatments: Best Practices for Prevention and Management". The panel, moderated by Ge
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
5. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
9. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
10. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
11. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2008)...ww.christmasseals.org to learn more, make a donat...SHINGTON, Nov. 17 Milli...month, courtesy of the American Lung Association. ...ual fundraising tradition dating back to 1907 when...culosis. , , "Most Americans alive today ...
(Date:11/18/2008)...E, Va., Nov. 18 Forty-t...ed at a November national forum to consider cuttin...c health and national economy from outbreaks of da...ed today. , , Among those innovations: , ...merican kitchen table that detects highly contagio...
(Date:11/18/2008)...ed study will enroll newly diagnosed, elderly AML ...wswire/ -- Celator Pharmaceuticals today announced...omized Phase 2 clinical study of CPX-351 (Cytarabi...th newly diagnosed acute myeloid leukemia (AML). ,...eldman, MD at the Weill Medical College of Cornel...
(Date:11/13/2008)...Study Suggests Nutritional Supplements Prior to Su...re-USNewswire/ -- Identifying,malnutrition before ...dy,contouring will significantly decrease surgical...scar quality and boost patient energy levels,acco...and Reconstructive,Surgery(R), the official medica...
Breaking Medicine Technology:American Lung Association Celebrates 101st Annual Christmas Seals Campaign 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference 314 1Nitec Pharma AG Announces Appointments of CEO 26 CFO in Preparation for Launch of Lodotra 28R 29 311 1Nitec Pharma AG Announces Appointments of CEO 26 CFO in Preparation for Launch of Lodotra 28R 29 311 2Nitec Pharma AG Announces Appointments of CEO 26 CFO in Preparation for Launch of Lodotra 28R 29 311 3Society for General Microbiology 161st Meeting University of Edinburgh 217 1Society for General Microbiology 161st Meeting University of Edinburgh 217 2A drug sensitive traffic cop tells potassium channels to get lost 364 1A drug sensitive traffic cop tells potassium channels to get lost 364 2
..., Germany, May 31, 2007- Results from various,clin...n patients,with advanced hepatocellular carcinoma,...tablets will be presented at the Annual,Meeting of...in,Chicago, USA from June 1 - 5, 2007. , On this o...ts,will be held on June 4, 2007. Starting at aroun...
...f Abstracts Reflects Continued Growth of Eisai,s,C...1, 2007 /PRNewswire/ -- Eisai,announced today that...eir oncology pipeline compounds have been accepted...cal Oncology (ASCO),annual meeting. ASCO takes pla...ts reveal a growing and diverse oncology clinical,...
Other Medicine Technology:Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 2Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 3Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 4
(Date:11/21/2008)... Nov. 21 Heska Corporati...ent at the New York Society of,Security Analysts,...ce on,December 2, 2008 at 1177 Avenue of the Amer... is scheduled to begin at 9:35 a.m. Eastern Time (...a live webcast and for two weeks,following the pr...
(Date:11/21/2008)...remain cautious about future antibiotic resistance...21 (HealthDay News) -- People with moderate to sev...ay be able to reduce the frequency of exacerbation...ic, a new report says. , The study, published ...ournal of Respiratory and Critical Care Medicine ,...
(Date:11/21/2008)... The University of Tex...ing of a collaborative effort to eradicate breast ...t Cancer Awareness and Research of the Americas to... the United States, and Vivian Fernandez de Torrij.... D. Anderson in the initiative are the U.S. Depar...
(Date:11/21/2008)...rs Intend To Vigorously Protect Investment And Res... 21 Dr. Stephen Joffe, ...ent to their Schedule 13D with the U.S. Securities...led a 13D disclosing ownership of 11.4% of LCA-Vis...ikPlus fixed-site laser vision correction centers ...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...y has selected Indian ministry of health and famil...or its "unrelenting stance on health promotion and... Welfare Anbumani Ramadoss will receive the award ...ce on Tobacco in Washington DC Friday, a ministry ...
...th African Indian Siamese twins are doing well and...nielle and Danika Lowton, born on June 21 at the A...ng their oral feeds. "They are gaining weight and...the Post newspaper quoted Wian Stander, head of th...
... live-saving stem cells, seven banks of umbilical ...st of the series will open in Gurgaon this// month...ks International, a US body, and R.J. Corporation ... will invest Rs.1 billion to build the seven repos...
...t was smuggled into the United States was found in...s over the past month. Michigan health// officials...to official reports there is no sign that the froz...rails intact, had been contaminated with the deadl...
Other Medicine News:Health News:First Cord Blood Bank in North India to be Opened in Gurgaon 2
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Round handle manufactured in titanium.
McPherson handle. 45 degree angled shafts. Manufactured in titanium.
Similar in construction to the E2002 Utrata Capsulorhexis Forceps with jaw set to open only 3 mm. Flat handle with dull finish.
Straight shafts with 4 mm platform. Wide serrated handle with dull finish. Platform straight.
Medicine Products: